Purchase Order 75N91024P00005
Award Date 11/1/23
Potential Completion Date 3/14/24
Potential Value $19K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Switzerland
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order by the National Cancer Institute within the National Institutes of Health, Department of Health and Human Services. The $25,000 purchase order is for testing services to support research efforts through January 31, 2025 with no set aside designation applied. As a privately owned data analytics and statistical consulting company based in Switzerland, Engene Statistics Sagl will...
- Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order by the National Cancer Institute within the National Institutes of Health, part of the Department of Health and Human Services. The $20,000 contract requires Engene to provide laboratory testing services in support of biomedical research projects involving high throughput data analysis. Performance will take place at the National Cancer Institute location in Bethesda, Maryland and...
- Engene Statistics GMBH, doing business as Engene Statistics Sagl, has been awarded a firm fixed price purchase order contract valued at $25,000 by the National Cancer Institute within the National Institutes of Health, part of the Department of Health and Human Services. The contract is for laboratory testing services to support the research efforts of the National Cancer Institute. Per the award notice, Engene will provide testing services with no subcontractors involved and no set aside...
- This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services, to Engene Statistics GMBH, doing business as Engene Statistics Sagl, a for-profit organization based in Switzerland. The $23,530.37 contract is for laboratory testing services to support biomedical research projects involving high throughput data analysis, particularly in the field of cancer...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order for $1 million to $5 million to Engene Statistics Sagl of Switzerland for laboratory testing services. Under this contract, Engene Statistics will provide testing support to advance the National Cancer Institute's biomedical research mission. As a small business located in Switzerland, Engene Statistics will leverage their scientific expertise to help...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,407 purchase order to Engene Statistics Sagl of Switzerland for testing services. Under the firm fixed price contract, Engene Statistics Sagl will provide unspecified testing services to the National Cancer Institute from July 31, 2023 through October 31, 2023. The contract was awarded directly to Engene Statistics Sagl as the prime contractor, with no mention of major...
- <p>The National Cancer Institute awarded a purchase order to Genepria Consulting Inc. for $15,000 on August 28, 2019, with an ultimate completion date of September 1, 2020. Work is performed in Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The vendor provides scientific consultation and data analysis services in support of biomedical research programs, including algorithm development and imaging system support.</p>
- <p>The National Cancer Institute awarded a purchase order to Innomics Inc. for $24,449.00 on September 22, 2020, for eukaryotic transcriptome resequencing. Work is performed in Cambridge, Massachusetts, with completion targeted for November 30, 2020. The order is a firm fixed-price acquisition for commercial genomic sequencing and bioinformatics services.</p>
- The National Cancer Institute awarded a purchase order to Genepria Consulting Inc. for $23,598.00 on March 25, 2016, with ultimate completion on March 26, 2017. The order is firm fixed price with no set-aside. Performance occurs in Bethesda, Maryland. The awardee provides scientific consultation and data analysis services in support of biomedical research programs at the National Cancer Institute, including scientific input, algorithm development, and imaging support for cancer research...
- The National Cancer Institute awarded a purchase order to Genepria Consulting Inc. for $62,073 on July 1, 2016. The order covers development of an integrated electron paramagnetic resonance oximetry suite operating at 400 MHz, implementation of novel pulse programs using a waveform generator, real-time visualization of Fourier transform EPR imaging, algorithms for co-registration of 400 MHz EPR images with other imaging modalities, oximetry by T2* mapping using single spin-echo pulse imaging...